Skip to main content
74°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Retail
From
CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
February 26, 2024
Tags
Breaking News: Markets
Pharmaceuticals
Zealand Pharma A/S
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Health Insurance
Health & Science
Drugs
From
CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
Tags
Pfizer Inc
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
February 06, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
February 05, 2024
Tags
Pharmaceuticals
Business
Breaking news
From
CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
January 31, 2024
Tags
Breaking News: Markets
Breaking News: Investing
Europe Markets
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
JetBlue Airways Corp
Business
Economy
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
Eli Lilly and Co
Health care industry
Johnson & Johnson
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
Structure Therapeutics Inc
Business
Pharmaceuticals
From
CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
January 08, 2024
Tags
Compute Health Acquisition Corp
Eli Lilly and Co
Kraft Heinz Co
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Business News
Health & Science
AstraZeneca PLC
From
CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
Tags
Dexcom Inc
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Pharmaceuticals
Business
Business News
From
CNBC.com News
5 things to know before the stock market opens Monday
December 18, 2023
Tags
Business
5 Things to Know
Nike Inc
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Biotechnology
AstraZeneca PLC
US: News
From
CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
December 11, 2023
Tags
Science
Pharmaceuticals
Business
From
CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
December 05, 2023
Tags
Biotechnology
US: News
Companies
From
CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
December 05, 2023
Tags
Breaking News: Markets
Breaking News: Investing
Europe Markets
From
CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
December 04, 2023
Tags
Novo Nordisk A/S
Jacobs Solutions Inc
Markets
From
CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
December 02, 2023
Tags
Novo Nordisk A/S
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Clinical trials
Eli Lilly and Co
Health care industry
From
CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
Tags
Eli Lilly and Co
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
Tags
Business
Investment Strategy
Stock markets
From
CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
Tags
Biotechnology
US: News
Companies
From
CNBC.com News
5 things to know before the stock market opens Monday
November 13, 2023
Tags
Target Corp
Business
Walmart Inc
From
CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
November 11, 2023
Tags
Health & Science
Novo Nordisk A/S
Business News
From
CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
Tags
Home Depot Inc
Investing
U/S/ Markets
From
CNBC.com News
Cramer's Lightning Round: Buy AutoZone
November 09, 2023
Tags
S&P 500
Aehr Test Systems
Mad Money
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.